Patent details

Basic Information

Publication number:

EP2968155

PCT Application Number:

IB2014059689

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP147264105

PCT Publication Number:

WO2014147526

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

French Title of Invention:

FORMES PHARMACEUTIQUES ORALES DE TOFACITINIB À LIBÉRATION PROLONGÉE

German Title of Invention:

ORALE TOFACITINIB-DARREICHUNGSFORMEN MIT VERZÖGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

12/03/2014

Grant date:

03/03/2021

EP Publication Date:

20/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/03/2021

EP B1 Publication Date:

03/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

12/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/04/2023

 

 

Name:

Pfizer Inc.

Address:

66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

History of Owners

From:

14/03/2023

To:

21/04/2023

Name:

PFIZER INC.

Address:

66 Hudson Boulevard East, NY 10001-2192, New York, United States (US)

From:

24/02/2021

To:

14/03/2023

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/03/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HERBIG, Scott Max

Address:

United States (US)

2

Name:

KRISHNASWAMI, Sriram

Address:

United States (US)

3

Name:

STOCK, Thomas C.

Address:

United States (US)

4

Name:

KUSHNER IV, Joseph

Address:

United States (US)

5

Name:

LAMBA, Manisha

Address:

United States (US)

Priority

1

Priority Number:

201361802479 P

Priority Date:

16/03/2013

Priority Country:

United States (US)

2

Priority Number:

201361864059 P

Priority Date:

09/08/2013

Priority Country:

United States (US)

3

Priority Number:

201461934428 P

Priority Date:

31/01/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/28; A61K 9/48; A61K 31/519; A61P 1/04; A61P 17/06; A61P 19/02; A61P 37/06;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/05

Publication date:

04/04/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202109

Publication date:

03/03/2021

Description:

Grant (B1)

2

Issue number:

202112

Publication date:

24/03/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202321

Publication date:

24/05/2023

Description:

Change of owner's name or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000113A

Date Registered:

14/03/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

PFIZER INC.

Address:

66 Hudson Boulevard East, NY 10001-2192, New York, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

13

Annual Fee Amount:

180 Euro

Expected Payer:

Last Annual Fee Payment Date:

12/02/2025

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
14/03/2023	Request For Change	1
14/03/2023	Request For Change	1
16/03/2023	Outgoing Correspondence	3
08/03/2021	Power Of Attorney	1
12/03/2021	Outgoing Correspondence	1